Dr. Breese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Cincinnati, OH 45229Phone+1 513-636-4266Fax+1 513-636-3549
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Indiana University School of MedicineResidency, Pediatrics, 2008 - 2011- Indiana University School of MedicineClass of 2008
Indiana University School of MedicinePhD, Biochemistry and Molecular Biology, 2002 - 2006
Certifications & Licensure
CA State Medical License 2011 - Present
OH State Medical License 2015 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma Start of enrollment: 2018 Sep 27
- A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia Start of enrollment: 2024 Jan 08
Roles: Contact
- Expanded Access Program for Revumenib
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsUse of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.Erin H. Breese, Corina Buechele, Catherine Dawson, Michael L. Cleary, Matthew H. Porteus
Plos One. 2015-09-09 - 19 citationsPreclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, Sung K Chiu, Vincent Kuek
Leukemia. 2023-01-01 - 43 citationsMLL leukemia induction by genome editing of human CD34+ hematopoietic cellsCorina Buechele, Erin H. Breese, Dominik Schneidawind, Chiou-Hong Lin, Johan Jeong
Blood. 2015-10-01
Abstracts/Posters
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaErin H. Breese, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Predicting Drug Response and Novel Therapeutic Candidates Using Signatures of Molecular Alterations in Hematologic Malignancies2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- In Vitro Approach for the Identification of Exceptional Responders in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Fellow
- American Society of Pediatric Hematology/OncologyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
